Key Points
Morgan Stanley maintains Overweight on BASFY with EUR 60 price target.
BASF trades at $15.83 with $55.9B market cap and 4.19% dividend yield.
Meyka AI rates BASFY as B grade with Hold recommendation.
Eight analysts rate Buy, three Hold, one Sell on BASFY consensus.
Morgan Stanley kept its Overweight rating on BASF SE (BASFY) on May 12, 2026, signaling confidence in the chemical giant’s outlook. The analyst firm raised its price target to EUR 60 from EUR 58, reflecting modest upside potential. BASF trades at $15.83 with a market cap of $55.9 billion. The BASFY analyst rating maintains steady conviction despite industry headwinds. This action underscores Morgan Stanley’s belief in BASF’s resilience across its six business segments, from chemicals to agricultural solutions.
Morgan Stanley’s Overweight Stance on BASFY
Rating Maintained with Confidence
Morgan Stanley held its Overweight rating on BASFY, demonstrating continued conviction in the stock. The analyst firm raised its price target to EUR 60 from EUR 58, a modest 3.4% increase. This BASFY analyst rating reflects Morgan Stanley’s view that the chemical leader offers value despite near-term market uncertainty. The price target adjustment signals the firm sees upside potential over the next 12 months.
Current Trading Dynamics
BASF trades at $15.83 per share, up 0.44% on the day. The stock has gained 21.76% year-to-date and 26.75% over the past year, outpacing many peers. Volume remains steady at 180,022 shares traded, slightly below the 221,225-share average. The company’s $55.9 billion market cap positions it as a global chemical powerhouse with deep market influence.
Financial Metrics and Valuation
Key Valuation Ratios
BASF trades at a P/E ratio of 27.06, reflecting investor expectations for future growth. The price-to-sales ratio of 0.79 suggests reasonable valuation relative to revenue generation. Free cash flow yield stands at 3.37%, providing income-focused investors with meaningful returns. The dividend yield of 4.19% makes BASFY attractive for income strategies. Meyka AI rates BASFY with a grade of B, suggesting a neutral hold stance. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.
Growth and Profitability Trends
Net income grew 24.7% year-over-year, while earnings per share increased 25.5%. Free cash flow surged 79.5%, demonstrating operational strength. However, revenue declined 2.9%, indicating pricing pressure in commodity chemicals. Operating margins sit at 4.85%, while net margins are 2.90%. BASFY faces mixed signals: strong earnings growth offset by revenue headwinds.
Analyst Consensus and Market Outlook
Broader Analyst Coverage
The consensus view on BASFY remains constructive. Eight analysts rate the stock as Buy, three as Hold, and one as Sell. This distribution reflects cautious optimism about the chemical sector’s recovery. Morgan Stanley raised its price target to EUR 60, aligning with broader bullish sentiment. The consensus rating of 3.0 (Buy) suggests the market expects modest appreciation ahead.
Sector and Industry Context
BASF operates in the Basic Materials sector and Chemicals industry, both cyclical and sensitive to economic growth. The company’s six segments span petrochemicals, advanced materials, industrial solutions, surface technologies, nutrition and care, and agricultural solutions. This diversification provides resilience during downturns. Earnings are expected on July 29, 2026, which could shift analyst sentiment.
Technical Setup and Price Forecasts
Technical Indicators
The RSI of 54.92 indicates neutral momentum, neither overbought nor oversold. The MACD histogram of -0.08 suggests slight downward pressure, though the signal remains weak. The ADX of 19.26 shows no clear trend, reflecting consolidation. Bollinger Bands place the stock near the middle band at $15.69, with upper resistance at $16.26 and support at $15.13. This tight range suggests traders await catalysts.
AI Price Forecasts
Meyka AI forecasts BASFY at $13.57 by year-end 2026, implying downside risk. The three-year forecast rises to $14.42, while the five-year target reaches $15.23. These projections suggest limited upside from current levels over the medium term. However, the seven-year forecast of $16.50 indicates long-term recovery potential as the chemical cycle improves.
Final Thoughts
Morgan Stanley’s maintained Overweight rating and raised price target of EUR 60 reflect confidence in BASF’s long-term positioning despite near-term headwinds. The BASFY analyst rating underscores the chemical giant’s diversified portfolio and strong cash generation. With a B grade from Meyka AI and mixed technical signals, BASF appears fairly valued for patient investors. The stock’s 4.19% dividend yield and 25.5% EPS growth offer compelling reasons to hold. Upcoming earnings on July 29 will be critical for validating analyst optimism. Investors should monitor commodity price trends and economic data closely before making decisions.
FAQs
Morgan Stanley maintains an Overweight rating with a EUR 60 price target, raised from EUR 58. This reflects confidence in BASF’s fundamentals and growth prospects despite cyclical industry challenges.
Consensus is Buy (3.0) with eight Buy, three Hold, and one Sell rating. This distribution reflects cautious optimism about BASF’s recovery and valuation, though some analysts remain concerned about near-term risks.
Meyka AI rates BASFY with a B grade, suggesting Hold. This incorporates S&P 500 benchmarks, sector performance, financial growth, key metrics, and analyst consensus.
Yes, BASFY offers a 4.19% dividend yield with a 126% payout ratio, indicating strong income generation. However, the high payout ratio limits dividend growth without earnings acceleration.
Key risks include declining revenue (-2.9% YoY), cyclical chemical industry exposure, and weak technical momentum. Economic slowdown could pressure margins and trigger analyst downgrades.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)